Recent research from England is shedding new light on smoking cessation, substance use treatment, and the effectiveness of cannabis-based medicines. A study led by Queen Mary University of London found that smokers who continue to vape after quitting traditional cigarettes are less likely to relapse. According to the researchers, individuals who used e-cigarettes as a quitting aid were more successful at permanently quitting smoking than those who relied on nicotine patches or gum.

In related news, scientists are exploring new uses for established smoking-cessation medications. A study published by the Society for the Study of Addiction reports that varenicline, commonly known by its brand name Chantix, may also help reduce cannabis use among people struggling to quit. Researchers note that cannabis use disorder is becoming an increasing global concern, particularly as legalization expands in many parts of the world.

Meanwhile, questions remain about the medical benefits of cannabis for chronic pain. A review published in the Cochrane journal found no clear evidence that cannabis-based medicines effectively relieve chronic neuropathic pain. While some patients using products containing both THC and CBD reported minor improvements, researchers concluded that the benefits were not significant enough to be considered clinically meaningful.